First Allied Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $249K | Buy |
2,237
+102
| +5% | +$11.4K | 0.01% | 977 |
|
|
2020
Q2 | $239K | Sell |
2,135
-451
| -17% | -$50.5K | 0.01% | 927 |
|
|
2020
Q1 | $200K | Sell |
2,586
-295
| -10% | -$22.8K | 0.01% | 943 |
|
|
2019
Q4 | $270K | Sell |
2,881
-69
| -2% | -$6.47K | 0.01% | 984 |
|
|
2019
Q3 | $221K | Buy |
2,950
+302
| +11% | +$22.6K | 0.01% | 1051 |
|
|
2019
Q2 | $232K | Sell |
2,648
-89
| -3% | -$7.8K | 0.01% | 1026 |
|
|
2019
Q1 | $244K | Sell |
2,737
-605
| -18% | -$53.9K | 0.01% | 968 |
|
|
2018
Q4 | $238K | Sell |
3,342
-30,303
| -90% | -$2.16M | 0.01% | 881 |
|
|
2018
Q3 | $3.23M | Buy |
33,645
+25,379
| +307% | +$2.43M | 0.11% | 211 |
|
|
2018
Q2 | $786K | Sell |
8,266
-17
| -0.2% | -$1.62K | 0.03% | 526 |
|
|
2018
Q1 | $727K | Buy |
8,283
+5,979
| +260% | +$525K | 0.03% | 545 |
|
|
2017
Q4 | $195K | Buy |
+2,304
| New | +$195K | 0.01% | 1068 |
|
|
2017
Q2 | – | Sell |
-13,866
| Closed | -$962K | – | 1198 |
|
|
2017
Q1 | $962K | Buy |
13,866
+7,439
| +116% | +$516K | 0.05% | 388 |
|
|
2016
Q4 | $380K | Sell |
6,427
-1,237
| -16% | -$73.1K | 0.02% | 689 |
|
|
2016
Q3 | $508K | Buy |
7,664
+2,940
| +62% | +$195K | 0.03% | 560 |
|
|
2016
Q2 | $257K | Buy |
4,724
+616
| +15% | +$33.5K | 0.01% | 813 |
|
|
2016
Q1 | $212K | Sell |
4,108
-204
| -5% | -$10.5K | 0.01% | 881 |
|
|
2015
Q4 | $306K | Buy |
4,312
+178
| +4% | +$12.6K | 0.02% | 761 |
|
|
2015
Q3 | $256K | Sell |
4,134
-1,791
| -30% | -$111K | 0.01% | 814 |
|
|
2015
Q2 | $496K | Sell |
5,925
-174
| -3% | -$14.6K | 0.02% | 617 |
|
|
2015
Q1 | $467K | Buy |
+6,099
| New | +$467K | 0.03% | 598 |
|